Position in ZTS
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$4,481,692
-$3,912,518 QoQ
Shares Held
62,367
-12.2% QoQ
Ownership
0.015%
of shares outstanding
% of Portfolio
0.11%
of 13F equity value
Holder Rank
#361
of 1,414 holders
Holding Since
Dec 2024
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ZTS Over Time
Shares Held
Position Value (USD)
Derivatives in ZTS
reported options exposure · as of Mar 31, 2026CallValue
$59,105
CallShares
500
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026PEAK6 LLC holds $6,524,525 across 3 Drug Manufacturers - Specialty & Generic names. ZTS ranks #1 (68.7% of the industry book) .
All Filings in ZTS
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,481,692 | 62,367 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $59,105 | 500 | Call | Defined | 2026-05-14 | |
| 2026-03-31 | $8,394,210 | 71,011 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $62,910 | 500 | Call | Defined | 2026-03-12 | |
| 2025-12-31 | $8,969,456 | 71,288 | Shares | Defined | 2026-03-12 | |
| 2025-12-31 | $2,013,120 | 16,000 | Put | Defined | 2026-03-12 | |
| 2025-09-30 | $1,390,040 | 9,500 | Put | Defined | 2026-03-31 | |
| 2025-06-30 | $1,481,525 | 9,500 | Put | Defined | 2025-08-14 | |
| 2024-12-31 | $358,446 | 2,200 | Put | Defined | 2025-02-13 | |
| 2024-12-31 | $437,304 | 2,684 | Shares | Defined | 2025-02-13 | |
| No filing history on record for this holder in this stock. | ||||||